Literature DB >> 36029434

Molecular Characterization of Four Mexican Isolates of Trypanosoma cruzi and Their Profile Susceptibility to Nifurtimox.

López-Domínguez Jaime1,2, López-Monteon Aracely1,3, Ochoa-Martínez Paulina1,2, Eric Dumonteil4, Christian Barnabé5, Etienne Waleckx3,5,6, Rubén Gustavo Hernández-Giles1,7, Angel Ramos-Ligonio8,9.   

Abstract

PURPOSE: The objective of this study was to molecularly characterize Mexican isolates of T. cruzi obtained from infected triatomine bugs (the vectors of T. cruzi) and to evaluate their susceptibility to Nifurtimox (NFX).
METHODS: Three isolates obtained from Triatoma dimidiata (collected in the State of Veracruz) and one isolate obtained from Triatoma bassolsae (collected in the State of Puebla) were molecularly characterized and the expression of genes associated with natural resistance to NFX was analyzed by qPCR.
RESULTS: Molecular characterization by PCR showed that isolates Zn3, Zn5, and SRB1 belong to the DTU TcI, while isolate Sum3 belongs to TcIV. The latter was also confirmed by sequencing of mitochondrial genes. Isolate Zn5 was the most sensitive to treatment with NFX (IC50, 6.8 μM), isolates SRB1 and Zn3 were partially resistant (IC50, 12.8 μM and 12.7 μM) and isolate Sum3 showed a high degree of resistance to NFX (IC50, 21.4 µM). We also found an association between decreased NTR1 or OYE gene expression with NFX resistance.
CONCLUSION: Our results also evidenced a high variability in the susceptibility to NFX of these T. cruzi isolates Central and Southeastern Mexico, suggesting the presence of naturally resistant isolates circulating in the country. These results have important implications for defining treatment policies for patients with Chagas disease.
© 2022. The Author(s) under exclusive licence to Witold Stefański Institute of Parasitology, Polish Academy of Sciences.

Entities:  

Keywords:  Chagas disease; DTUs; Mexican isolates; Nifurtimox; Puebla; Resistance genes; Trypanosoma cruzi; Veracruz

Year:  2022        PMID: 36029434     DOI: 10.1007/s11686-022-00608-3

Source DB:  PubMed          Journal:  Acta Parasitol        ISSN: 1230-2821            Impact factor:   1.534


  37 in total

Review 1.  Trypanosoma cruzi genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity.

Authors:  Bianca Zingales
Journal:  Acta Trop       Date:  2017-09-21       Impact factor: 3.112

2.  Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease.

Authors:  Margoth Moreno; Daniella A D'ávila; Marcelo N Silva; Lúcia Mc Galvão; Andrea M Macedo; Egler Chiari; Eliane D Gontijo; Bianca Zingales
Journal:  Mem Inst Oswaldo Cruz       Date:  2010-11       Impact factor: 2.743

3.  A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI.

Authors:  B Zingales; S G Andrade; M R S Briones; D A Campbell; E Chiari; O Fernandes; F Guhl; E Lages-Silva; A M Macedo; C R Machado; M A Miles; A J Romanha; N R Sturm; M Tibayrenc; A G Schijman
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-11       Impact factor: 2.743

4.  Genetic diversity of Trypanosoma cruzi in bats, and multilocus phylogenetic and phylogeographical analyses supporting Tcbat as an independent DTU (discrete typing unit).

Authors:  Luciana Lima; Oneida Espinosa-Álvarez; Paola A Ortiz; Javier A Trejo-Varón; Julio C Carranza; C Miguel Pinto; Myrna G Serrano; Gregory A Buck; Erney P Camargo; Marta M G Teixeira
Journal:  Acta Trop       Date:  2015-07-19       Impact factor: 3.112

5.  Gene expression study using real-time PCR identifies an NTR gene as a major marker of resistance to benzonidazole in Trypanosoma cruzi.

Authors:  Ana M Mejía-Jaramillo; Geysson J Fernández; Lina Palacio; Omar Triana-Chávez
Journal:  Parasit Vectors       Date:  2011-09-05       Impact factor: 3.876

Review 6.  Chagas Disease: From Discovery to a Worldwide Health Problem.

Authors:  Kárita Cláudia Freitas Lidani; Fabiana Antunes Andrade; Lorena Bavia; Flávia Silva Damasceno; Marcia Holsbach Beltrame; Iara J Messias-Reason; Thaisa Lucas Sandri
Journal:  Front Public Health       Date:  2019-07-02

7.  In vitro susceptibility of Trypanosoma cruzi discrete typing units (DTUs) to benznidazole: A systematic review and meta-analysis.

Authors:  Andrea Vela; Marco Coral-Almeida; Denis Sereno; Jaime A Costales; Christian Barnabé; Simone Frédérique Brenière
Journal:  PLoS Negl Trop Dis       Date:  2021-03-22

8.  Differential trypanocidal activity of novel macrolide antibiotics; correlation to genetic lineage.

Authors:  Carolina Aquilino; Maria Luisa Gonzalez Rubio; Elena Maria Seco; Leticia Escudero; Laura Corvo; Manuel Soto; Manuel Fresno; Francisco Malpartida; Pedro Bonay
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

Review 9.  Experimental and Clinical Treatment of Chagas Disease: A Review.

Authors:  Policarpo Ademar Sales Junior; Israel Molina; Silvane Maria Fonseca Murta; Adrián Sánchez-Montalvá; Fernando Salvador; Rodrigo Corrêa-Oliveira; Cláudia Martins Carneiro
Journal:  Am J Trop Med Hyg       Date:  2017-10-10       Impact factor: 2.345

10.  Phenotypic diversity and drug susceptibility of Trypanosoma cruzi TcV clinical isolates.

Authors:  Luz P Quebrada Palacio; Mariela N González; Yolanda Hernandez-Vasquez; Alina E Perrone; Adriana Parodi-Talice; Jacqueline Bua; Miriam Postan
Journal:  PLoS One       Date:  2018-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.